Reply to "Switch from ustekinumab to guselkumab in patients with psoriasis in real clinical practice using the "minimal disease activity" parameter"
Articolo
Data di Pubblicazione:
2022
Citazione:
Reply to "Switch from ustekinumab to guselkumab in patients with psoriasis in real clinical practice using the "minimal disease activity" parameter" / G. Murgia, C.A. Maronese, C.G. Carrera, A. Cattaneo, A.V. Marzano. - In: DERMATOLOGIC THERAPY. - ISSN 1529-8019. - 35:8(2022 Aug), pp. e15644.1-e15644.3. [Epub ahead of print] [10.1111/dth.15644]
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
Antibodies, Monoclonal, Humanized; Humans; Psoriasis; Ustekinumab
Elenco autori:
G. Murgia, C.A. Maronese, C.G. Carrera, A. Cattaneo, A.V. Marzano
Link alla scheda completa: